Can Cell Kinetic Parameters Predict the Response of Tumours to Radiotherapy?

References

• Begg A.C., McNally N.J., Shrieve D.C., Karcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985; 6: 620–626
   PubMedGoogle Scholar
• Begg A.C., Moonen L., Hofland I., Dessing M., Bartelink H. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: Intratumour sampling variations. Radiotherapy and Oncology 1988; 11: 337–348
   PubMed Web of Science ®Google Scholar
• Chauvel P., Courdi A., Gioanni J., Vallicioni J., Santini J., Demard F. The labelling index: a prognostic factor in head and neck cancer. Radiotherapy and Oncology 1989; 14: 231–238
   PubMed Web of Science ®Google Scholar
• Costa A., Salvatori P., Molinari R., Motta R., Cerutti A., Silvestrini R. Cell kinetics to monitor radioresponsivity in human epidermoid cancer. Basic and Applied Histochemistry 1986; 30: 209–213
   PubMedGoogle Scholar
• Courdi A., Tubiana M., Chavaudra N., Malaise E. Changes in labelling indices of human tumours after irradiation. International Journal of Radiation Oncology, Biology and Physics 1980; 6: 1639–1644
   PubMed Web of Science ®Google Scholar
• Dische S., Saunders M.-I., Bennet M.H., Wilson G.D., McNally N.J. Cell proliferation and differentiation in squamous cancer. Radiotherapy and Oncology 1989; 15: 19–23
   PubMed Web of Science ®Google Scholar
• Fowler J.F. Potential for increasing the differential response between tumours and normal tissues: can proliferation rate be used?. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 641–645
   PubMed Web of Science ®Google Scholar
• Friedlander M.L. Flow cytometric analysis of archival tumour specimens. Prediction of Tumour Treatment Response, J.D. Chapman, L.J. Peters, H.R. Withers. Pergamon Press, Oxford 1988; 77–96, In
   Google Scholar
• Friedlander M.L., Taylor I.W., Russell P., Tattersall M. Cellular DNA content—a stable marker in epithelial ovarian cancer. British Journal of Cancer 1984; 49: 173–179
   PubMed Web of Science ®Google Scholar
• Headley D.W., Friedlander M.L., Taylor I.W., Rugg C.A., Musgrove E.A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. Journal of Histochemistry and Cytochemistry 1983; 11: 1333–1335
   Google Scholar
• Holsti L.R., Mantyla M. Split-course versus continuous radiotherapy. Acta Oncologica 1988; 27: 153–161
   PubMed Web of Science ®Google Scholar
• Meyer J.S. Potential value of cell kinetics in management of cancers of unknown origin. Seminars in Oncology 1982; 9: 513–516
   PubMed Web of Science ®Google Scholar
• Meyer J.S., Connor R.E. In vitro labelling of solid tissue with tritiated thymidine for autoradiographic determination of S-phase nuclei. Stain Technology 1977; 52: 185–192
   PubMed Web of Science ®Google Scholar
• Meyer J.S., Friedman E., McCrate M.M., Bauer W.C. Prediction of early course of breast carcinoma by thymidine labelling. Cancer 1983; 51: 1879–1886
   PubMed Web of Science ®Google Scholar
• Nakamura H., Morita T., Masaki S., Yoshida S. Intracellular localisation and metabolism of DNA polymerase α in human cells visualised with a monoclonal antibody. Experimental Cell Research 1984; 151: 123–133
   PubMed Web of Science ®Google Scholar
• Overgaard J., Hjelm-Hansen L., Johansen V., Andersen A.P. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncologica 1988; 27: 147–152
   PubMed Web of Science ®Google Scholar
• Silvestrini R. Human tumour cell cycle parameters. Prediction of Tumour Treatment Response, J.D. Chapman, L.J. Peters, H.R. Withers. Pergamon Press, Oxford 1988; 97–109, In
   Google Scholar
• Silvestrini R., Daidone M.G., Gasparini G. Cell kinetics as a prognostic marker in node-negative breast cancer. Cancer 1985; 56: 1982–1987
   PubMed Web of Science ®Google Scholar
• Steel G.G., Bensted J.P.M. In vitro studies of cell proliferation in tumours. European Journal of Cancer 1965; 1: 275–279
   PubMedGoogle Scholar
• Trott K.-R., Kummermehr J. What is known about tumour proliferation to choose between accelerated fractionation or hyperfractionation?. Radiotherapy and Oncology 1985; 3: 1–9
   PubMed Web of Science ®Google Scholar
• Tubiana M., Pejovic M.H., Chavaudra N., Contesso G., Malaise E.P. The long-term prognostic significance of the thymidine labelling index in breast cancer. International Journal of Cancer 1984; 33: 441–445
   PubMed Web of Science ®Google Scholar
• Vanderlaan M., Watkins B., Thomas C., Dolberare F., Stanker L. Improved high-affinity monoclonal antibody to iododeoxyuridine. Cytometry 1986; 7: 499–507
   PubMedGoogle Scholar
• Wilson G.D., McNally N.J., Dunphy E., Karcher H., Pfragner R. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry 1985; 6: 641–647
   PubMedGoogle Scholar
• Wilson G.D., McNally N.J., Dische S., Saunders M.I., Des Rochers C., Lewis A.A., Bennett M.H. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. British Journal of Cancer 1988; 58: 423–431
   PubMed Web of Science ®Google Scholar
• Withers H.R., Taylor J.M.G., Maceijewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncologica 1988; 27: 131–146
   PubMed Web of Science ®Google Scholar